Eton Pharmaceuticals (ETON) Research & Development (2019 - 2025)
Historic Research & Development for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $1.1 million.
- Eton Pharmaceuticals' Research & Development rose 12019.8% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year decrease of 114.05%. This contributed to the annual value of $3.3 million for FY2024, which is 201.69% down from last year.
- As of Q3 2025, Eton Pharmaceuticals' Research & Development stood at $1.1 million, which was up 12019.8% from $3.7 million recorded in Q2 2025.
- Eton Pharmaceuticals' Research & Development's 5-year high stood at $3.7 million during Q2 2025, with a 5-year trough of -$871000.0 in Q4 2024.
- Over the past 5 years, Eton Pharmaceuticals' median Research & Development value was $944000.0 (recorded in 2022), while the average stood at $1.2 million.
- Within the past 5 years, the most significant YoY rise in Eton Pharmaceuticals' Research & Development was 16400.0% (2024), while the steepest drop was 18319.01% (2024).
- Quarter analysis of 5 years shows Eton Pharmaceuticals' Research & Development stood at $681000.0 in 2021, then surged by 38.62% to $944000.0 in 2022, then rose by 10.91% to $1.0 million in 2023, then tumbled by 183.19% to -$871000.0 in 2024, then surged by 227.67% to $1.1 million in 2025.
- Its Research & Development was $1.1 million in Q3 2025, compared to $3.7 million in Q2 2025 and $1.2 million in Q1 2025.